Efficacy and safety of nedaplatin-based concurrent chemoradiotherapy for FIGO Stage IB2–IVA cervical cancer and its clinical prognostic factors

Cisplatin-based concurrent chemoradiotherapy (CCRT) is a standard treatment for cervical cancer, but nedaplatin-based CCRT is not routinely administered. We evaluated the efficacy and safety of nedaplatin-based CCRT (35 mg/m(2) weekly) and analyzed prognostic factors for survival among 52 patients w...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Radiat Res
Autors principals: Fujiwara, Masateru, Isohashi, Fumiaki, Mabuchi, Seiji, Yoshioka, Yasuo, Seo, Yuji, Suzuki, Osamu, Sumida, Iori, Hayashi, Kazuhiko, Kimura, Tadashi, Ogawa, Kazuhiko
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2015
Matèries:
Oncology
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4380049/
https://ncbi.nlm.nih.gov/pubmed/25428244
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jrr/rru101
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars